ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Company Info

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

3 Contributors1 / 1

1 / 1

7 Contributions1 / 1

1 / 1

Headquarters

130 Utopia Rd

Suite 12

Manchester, CT 06042

Visit the Website

DIANT Pharma

Drug Discovery & Development / Equipment

Overview

DIANT Pharma was founded in 2019 and has developed a continuous processing technology applicable for nanoparticle drug products and vaccines. We strive to offer a technology that is robust and reliable from R&D to manufacturing; over a product’s lifespan.

Our proprietary continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space.

We are always looking for partners to broaden the use of our technology. Please contact us.

Antonio Costa, Ph.D.

Antonio Costa, Ph.D.

Chief Executive Officer and Founder

William Pasek

William Pasek

Chief Commercial Officer

Jim Ziogas

Sales Engineer

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

PAO-05-24-CL-03May 30, 2024

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

PAO-03-24-CL-08Mar 18, 2024

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

PAO-10-23-CL-03Nov 01, 2023

Continuous Processing

US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.

DIANT Pharma

PR-M07-23-03Jul 31, 2023

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

PAO-04-23-CL-05May 06, 2023

Lipid Nanoparticles: Transforming the Nanomedicines Market

Lipid Nanoparticles

Lipid Nanoparticles: Transforming the Nanomedicines Market

Antonio Costa, Ph.D.

DIANT Pharma

PAO-02-23-CL-01Feb 07, 2023

Innovating Nanoparticles for Pharmaceutical Applications

Nanoparticles

Innovating Nanoparticles for Pharmaceutical Applications

DIANT Pharma

PAO-02-22-R250-18Feb 24, 2022